- Imidazole derivatives used in antithrombotic method
-
Compounds of the general formula: STR1 and acid addition salts thereof; in which Ar and Ar1 which may be the same or different, each represent an aromatic radical which may be substituted one or more times by substituents selected from the following: halogen; lower alkyl; lower alkoxy; alkylenedioxy; aralkoxy; aryloxy; trihalomethyl; carboxy; carboxyalkyl; cyano; carboxamido; di-lower alkylamino; nitro; and lower alkyl sulphonyl provided that one of the groups Ar and Ar1 carries at least one alkoxy, alkylenedioxy, carboxy or carboxyalkyl substituent; and Alk1 and Alk2, which may be the same or different, each represent an alkylene group containing from 1 to 8 carbon atoms which may be substituted one or more times by lower alkyl; X and Y which may be the same or different represent oxygen, nitrogen or sulphur; and in which the imidazole ring may be substituted by one or more lower alkyl substituents have antithrombotic activitiy. A representative compound is 1-[2-[(4-methoxyphenyl)methoxy]-3-[(4-methoxyphenyl)methoxy]propyl]-1H-imidazole.
- -
-
-
- Certain 1H-imidazol-1-yl-1-lower-alkanoic acid derivatives having anti-thrombotic activity
-
Compounds of the general formula STR1 and pharmaceutically acceptable salts thereof have antithrombotic activity. Het represents 1-[1H-imidazolyl], 1-N-morpholinyl or pyridyl. A representative compound is 6-[2-(1H-Imidazol-1-yl)-1-yl-1-[[(4-methoxyphenyl)methoxy]methyl]ethoxy]hexanoic acid.
- -
-
-